Survey on the usage of antiasthmatic drugs in community hospitals in Shanghai
10.3760/cma.j.issn.1671-7368.2015.05.007
- VernacularTitle:上海市社区医院平喘药物使用情况调查
- Author:
Xiaofen YE
;
Zhigang PAN
;
Yingyun CAI
;
Lubiao BU
;
Qianzhou Lü
;
Meiling JIN
- Publication Type:Journal Article
- Keywords:
Community health centers;
Anti-asthmatic agents;
Medication systems,hospital
- From:
Chinese Journal of General Practitioners
2015;14(5):336-339
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the usage of antiasthmatic drugs and seek problems of following the guidelines of asthma and COPD prevention & treatment in community hospitals.Methods The prescribed quantity in 2013 of antiasthmatic drugs was recorded for 5 community hospitals in a district of Shanghai.Basing on the defined daily dose (DDD),the dosing frequency of drugs (DDDs) and the percentages of each category of drugs were calculated.Then comparisons were made with the data of a grade Ⅱ hospital and a grade Ⅲ hospital in the same district.Results Among three level hospitals,no significant difference existed in the percentages of oral antiasthmatic drugs.But the major category of oral drugs at grades Ⅱ-Ⅲ hospitals was leukotriene receptor antagonist whereas only oral theophylline and oral β2-receptor agonists were available at community hospitals.Among inhaled drugs,inhaled corticosteroids (ICS) dominated at grades Ⅱ-Ⅲ hospitals.But at community hospitals,inhaled short-acting beta-agonists (SABA) predominated.Among inhalants,dry powder inhaler (DPI) dominated at grades Ⅱ-Ⅲ hospitals and metered dose inhaler (MDI) at community hospitals.Conclusions The usage of antiasthmatics at community hospitals is not consistent with the guidelines.Optimizing drug purchasing at hospitals,strengthening continued medical education,modifying the medication concept of patients and boosting the production of domestic inhalants should be urgently undertaken.
